None
Quote | Navidea Biopharmaceuticals Inc. (NYSE:NAVB)
Last: | $0.0779 |
---|---|
Change Percent: | 0.37% |
Open: | $0.08 |
Close: | $0.0779 |
High: | $0.08 |
Low: | $0.0764 |
Volume: | 1,030,238 |
Last Trade Date Time: | 10/05/2023 03:00:00 am |
News | Navidea Biopharmaceuticals Inc. (NYSE:NAVB)
Navidea Biopharmaceuticals, Inc. announced today the filing of Form 15 to voluntarily deregister and suspend SEC reporting obligations. The company maintains strategic focus on its Fix, Fund, Propel approach. Navidea Biopharmaceuticals, Inc. (OTC: NAVB) (“Navidea” or the &...
2023-12-01 12:03:58 ET More on Navidea Biopharm Financial information for Navidea Biopharm For further details see: Navidea settles litigation with Capital Royalty, stock rallies 30%
Message Board Posts | Navidea Biopharmaceuticals Inc. (NYSE:NAVB)
Subject | By | Source | When |
---|---|---|---|
NEWS -- Navidea Biopharmaceuticals, Inc. Announces Intent to | Paulness | investorshub | 04/28/2023 12:18:35 AM |
NEWS -- Navidea Biopharmaceuticals, Inc. Enters Asset Purchase | Paulness | investorshub | 04/14/2023 11:13:45 AM |
NEWS -- Navidea Biopharmaceuticals, Inc. Hires G2G Ventures | Paulness | investorshub | 03/31/2023 2:49:33 AM |
NEWS -- Q4 2022 Navidea Biopharmaceuticals Inc Earnings Call | Paulness | investorshub | 03/22/2023 1:20:21 PM |
NEWS -- Navidea Biopharmaceuticals to Host Fourth Quarter | Paulness | investorshub | 03/15/2023 12:29:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Navidea Biopharmaceuticals Inc. Company Name:
NAVB Stock Symbol:
NYSE Market:
Navidea Biopharmaceuticals, Inc. announced today the filing of Form 15 to voluntarily deregister and suspend SEC reporting obligations. The company maintains strategic focus on its Fix, Fund, Propel approach. Navidea Biopharmaceuticals, Inc. (OTC: NAVB) (“Navidea” or the &...
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. have entered into a binding settlement agreement and mutual release settling ongoing litigation. Navidea Biopharmaceuticals, Inc. (OTC: NAVB) (“Navidea” or the “Company”), a company focuse...
The Company announced today that the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the NYSE American LLC upheld the NYSE Regulation staff’s previously announced determination to initiate delisting proceedings with respect to the Company’s com...